NSE filing, NSE: GSPCROP. Summary written from the filing by ALFA Finder's alert engine.
GSP Crop Science Ltd: key numbers
- Share price
- ₹450.95
- Market cap
- ₹2,098 Cr
- Revenue (annual)
- ₹1,517 Cr
- Net profit (annual)
- ₹97.90 Cr
- P/E (TTM)
- 20.8×Sector 34.1×
- Promoter holding
- 71.73%+0.00% QoQ
- FII holding
- 9.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GSP Crop Science Ltd
All →GSP Crop Science Other Announcement
GSP Crop Science Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in accordance with SEBI regulatory requirements.
GSP Crop Science Management Change
Mr. Pranav Chitre has resigned as the company's Chief Financial Officer and Key Managerial Personnel, effective October 30, 2026.
GSP Crop Science Management Change
GSP Crop Science Limited has appointed Mr. Narayanan Pulukhool Nair as a Non-Executive Independent Director, effective August 11, 2026, for a five-year term.
GSP Crop Science Annual General Meeting
GSP Crop Science disclosed 41st AGM proceedings and scrutinizer's report from September 18, 2026. Seven resolutions included a ₹1 per share final dividend.
GSP Crop Science Price Movement Clarification
GSP Crop Science clarified that the recent rise in its trading volume is market-driven. The company confirmed no undisclosed material information impacts its stock price.
GSP Crop Science Other Announcement
GSP Crop Science Limited has notified shareholders about the online availability of the Annual Report for FY 2025-26 and issued a reminder to update KYC details.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr